Chulalongkorn Pioneers Novel Sleep Apnea Surgery, Expanding Asian Adoption
Event summary
- Chulalongkorn University's Excellence Center for Sleep Disorders performed its fourth HGNS (Hypoglossal Nerve Stimulation) surgery for obstructive sleep apnea in Asia, and the first in Thailand.
- The procedure, first performed in the US over a decade ago, involves implanting a nerve stimulator to expand the airway.
- Three patients have undergone the HGNS procedure since July 2025, with reported minimal pain and promising results (AHI reduction >70%).
- The university received training from American institutions, including the University of Southern California and the Medical College of Wisconsin.
The big picture
The adoption of HGNS represents a shift towards more targeted surgical interventions for obstructive sleep apnea, moving beyond traditional tissue removal methods. While CPAP remains the standard treatment, HGNS offers a potential alternative for patients who are non-compliant or experience adverse effects. This development highlights the growing trend of personalized medicine and the increasing sophistication of medical technology in addressing chronic conditions, particularly in emerging markets like Thailand where the prevalence of sleep apnea is rising.
What we're watching
- Adoption Rate
- The pace at which other hospitals in Asia adopt HGNS surgery will depend on training availability and equipment costs, potentially limiting its widespread use.
- Regulatory Landscape
- Thailand’s regulatory framework for novel surgical techniques will influence the reimbursement landscape and patient access to HGNS, impacting its long-term viability.
- Competitive Dynamics
- The emergence of competing surgical techniques or devices for obstructive sleep apnea could erode the long-term market share of HGNS.
